Geratherm Medical (ETR:GME) Full Year 2023 Results

Key Financial Results

• Revenue: €23.2m (down 13% from FY 2022).

• Net income: €1.11m (up 8.6% from FY 2022).

• Profit margin: 4.8% (up from 3.9% in FY 2022). The increase in margin was driven by lower expenses.

• EPS: €0.21 (up from €0.19 in FY 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Geratherm Medical Earnings Insights

Looking ahead, revenue is forecast to stay flat during the next 2 years compared to a 6.7% growth forecast for the Medical Equipment industry in Germany.

Performance of the German Medical Equipment industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

Be aware that Geratherm Medical is showing 2 warning signs in our investment analysis that you should know about...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]